Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04803682 · ClinicalTrials.gov registry record · Early Phase 1
A Smoking Prevention Program (ASPIRE) and Mentoring for Preventing Smoking Among High School Youths
A Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 94
- Enrollment target
NCT04803682: Completed Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT04803682 is a Early Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 94 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (77% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04803682, a Early Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 94 participants
- Enrollment target
Study Summary
This early phase I trial studies how well A Smoking Prevention Interactive Experience (ASPIRE) program and mentorship works in preventing smoking in high school students. ASPIRE is an online-based, youth-centered tobacco prevention and cessation program. The goal of this research study is to learn if training eleventh grade high school students to be tobacco-free role models and mentors for ninth grade high school students is possible and will positively influence the younger peers.
Primary Outcome
At least 40 mentors and 100 mentees.
Interventions
- BEHAVIORAL Questionnaire Administration
- BEHAVIORAL Preventive Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2016-01-08 |
| Est. Completion | 2021-03-16 |
| Phase | Early Phase 1 |
What the finished NCT04803682 record still lists
NCT04803682 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (77% higher).
The record links to 0 conditions, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT04803682 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04803682 about?
NCT04803682 is a clinical study titled "A Smoking Prevention Program (ASPIRE) and Mentoring for Preventing Smoking Among High School Youths". This early phase I trial studies how well A Smoking Prevention Interactive Experience (ASPIRE) program and mentorship works in preventing smoking in high school students. ASPIRE is an online-based, youth-centered tobacco prevention and cessation program. The goal of this research study is to learn i...
What is the current status of trial NCT04803682?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 94 participants. The study started on 2016-01-08. Estimated completion is 2021-03-16.
What interventions are being tested in trial NCT04803682?
The interventions under investigation include: Questionnaire Administration (BEHAVIORAL), Preventive Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04803682?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04803682's enrollment target sits among peer trials
94 227th of 2000 higher than 1,773 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI